Syntis Bio, Inc. is a pioneering biotechnology company focused on transforming oral therapeutics through innovative solutions targeting the small intestine. By leveraging its proprietary SYNT™ platform, the company enhances the absorption and effectiveness of treatments for prevalent and challenging conditions such as obesity, diabetes, and rare diseases.
Company Values
Syntis Bio stands out with its mussel-inspired polymer chemistry technology that significantly improves drug bioavailability in the gastrointestinal tract.